Five things for pharma marketers to know: Tuesday, November 29, 2016

1. President-elect Trump selected Rep. Tom Price (R-GA) as the secretary of the Department of Health and Human Services. Price, a critic of the Affordable Care Act, has drafted several bills to replace the healthcare law. (WaPo)

2. Sen. Elizabeth Warren (D-MA) criticized the 21st Century Cures Act, claiming that the bill in general is full of giveaways to drugmakers and that a reporting exemption for CME would “cover up bribery.” (AP)

3. GlaxoSmithKline CEO Andrew Witty said drugmakers, in the wake of recent criticism around drug pricing, will likely have to get used to making less money. He noted, however, that large markets like the U.S. will still pay for innovation. (FT)

4. Momenta Pharmaceuticals' experimental biosimilar of AbbVie's Humira met its main goal in a Phase-III clinical trial for patients with psoriasis. (Reuters)

5. Pfizer and Eli Lilly often raise the list prices of erectile dysfunction drugs Viagra and Cialis around the same time. This strategy discredits the industry position that competition helps lower prices. (WSJ)